Pharmacoeconomic Education for Pharmacy Students in Bosnia and Herzegovina

Pharmacoeconomic (PE) is becoming more important in pharmaceutical reimbursement decision and drug evaluation. To ensure its appropriate application, conduction and assessment of studies it is important to have well trained and educated professionals. Pharmaceutical faculties all over the world have established PE in under- and post-graduate curricula’s. In this pilot research we examine situation in B&H. In Bosnia-Herzegovina, education in this field is poor and only one faculty for pharmacy has introduced PE as subject in its program. Objective of this study is to explore understanding of PE and its concept and analysis and to evaluated adopted knowledge among graduate (fifth year/tenth semester) pharmacy students who have listened subject “pharmacoeconomics” in previous semester. A self-administered questionnaire was developed consisted of 12 questions and survey was conducted among students. Results are analyzed in MS Excel and we used descriptive statistics. Even graduate students have lessons from PE they understand its scope and definition, but do not feel capable for conducting PE studies, but show interest in additional education and getting competencies in this field finding it applicable in their future professional engagements.

[1]  E. Cox,et al.  Principles of Pharmacoeconomics , 2015 .

[2]  T. Čatić Pharmacoeconomic Education for Health Care Students in Bosnia and Herzegovina , 2013 .

[3]  B. Begović,et al.  PHP126 Overview of HTA Process and Implementation Among Health Stakeholders in Bosnia and Herzegovina – Survey Based Research , 2011 .

[4]  E. Jonsson,et al.  History of HTA: Introduction , 2009, International Journal of Technology Assessment in Health Care.

[5]  K. Rascati,et al.  Pharmacoeconomic education in US colleges and schools of pharmacy: an update. , 2008, American journal of pharmaceutical education.

[6]  H. Hogerzeil,et al.  The concept of essential medicines: lessons for rich countries , 2004, BMJ : British Medical Journal.

[7]  T. Walley,et al.  Teaching safe and effective prescribing in UK medical schools: a core curriculum for tomorrow's doctors. , 2003, British journal of clinical pharmacology.

[8]  A Harris,et al.  Using economic evidence in reimbursement decisions for health technologies: experience of 4 countries , 2001, Expert review of pharmacoeconomics & outcomes research.

[9]  M. Drummond,et al.  Current trends in the use of pharmacoeconomics and outcomes research in europe. , 1999, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[10]  Y. Deshmukh,et al.  Introducing pharmacoeconomics (PE) in medical undergraduate curriculum , 2010 .

[11]  S. Kushare PHARMACOECONOMICS : A REVIEW , 2009 .

[12]  M. Singer Cost-effectiveness analysis: developing nations left behind. , 2008, PharmacoEconomics.

[13]  E. Tarin,et al.  Health Technology Assessment: Lessons to Learn , 2006 .

[14]  K. Rascati,et al.  Pharmacoeconomic Education in Colleges of Pharmacy Outside of the United States , 2005 .

[15]  P. Davey,et al.  Education in pharmacoeconomics: an international multidisciplinary view. , 2004, PharmacoEconomics.